Levetiracetam
Product Images NDC 70934-352

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 70934-352). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

70934 352 30 Master Bottle Label Approval Rev A 05 19

This is a medication bottle label for Levetiracetam tablets USP with a strength of 500mg. The bottle contains 30 tablets and has Lot number T68ty. No other information is available.*

FDA Label Image

D0b54345 900c 42f9 A3a2 D81e740d85aa 01

This text is a calculation formula for finding the total daily dose of a medication based on the patient's weight and the daily dose provided in milligrams per kilogram. The medication concentration is given as 100mg/mL.*

FDA Label Image

D0b54345 900c 42f9 A3a2 D81e740d85aa 02

This text appears to be explaining a formula for calculating CLer, which is a measure of kidney function in patients. The CLer value is calculated based on the patient's weight, age, and serum creatinine level. The formula is adjusted for body surface area (BSA) to provide a more accurate measurement. However, without additional context or information it is difficult to provide a more detailed description of how this calculation is used in practice.*

FDA Label Image

D0b54345 900c 42f9 A3a2 D81e740d85aa 03

FDA Label Image

D0b54345 900c 42f9 A3a2 D81e740d85aa 04

FDA Label Image

D0b54345 900c 42f9 A3a2 D81e740d85aa 05

This appears to be a table showing the percentages of patients at different levels of treatment for a study involving a placebo group and two different levels of treatment with Levetiracetam at 1000mg/day and 2000mg/day.*

FDA Label Image

D0b54345 900c 42f9 A3a2 D81e740d85aa 06

FDA Label Image

D0b54345 900c 42f9 A3a2 D81e740d85aa 07

The text represents a table showing the percentage of patients for two groups: Placebo (N=07) and Levetiracetam (N=101). The data is presented in the form of percentages for different categories that are not provided. Some of the categories have missing or unreadable values denoted by the symbol "%". There is no further information available to provide a more specific description of the data presented.*

FDA Label Image

D0b54345 900c 42f9 A3a2 D81e740d85aa 08

This text provides the percentage of patients in a study who were given either a placebo or levetiracetam, a medication for seizures. The study consisted of 51 patients who were given a placebo and 58 patients who were given levetiracetam. 19.6% of patients received the placebo and 43.1% received the medication.*

FDA Label Image

D0b54345 900c 42f9 A3a2 D81e740d85aa 09

This appears to be a chart or graph displaying the percentage of patients responding to a placebo versus levetiracetam treatment in a clinical trial. The vertical axis shows the percentage of patients in increments of 10 from 0-100%, and the horizontal axis likely shows different time points or dosages. The data shows that the percentage of patients responding to levetiracetam is higher than those responding to placebo across all time points or dosages. Unfortunately, without knowing more about the clinical trial, it is difficult to interpret the results more fully.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.